Location
United States, North America
Cheque size
$5K - $50K
Investment Stage
Focus Areas
About Investor
Anne Wojcicki is Founder and leader of the TTAM Research Institute, a nonprofit public benefit corporation she established in 2025 to acquire and continue operating 23andMe's Personal Genome Service and research business following 23andMe's Chapter 11 bankruptcy. She originally co-founded 23andMe in 2006 and served as its CEO until resigning in March 2025 amid the bankruptcy proceedings, before her nonprofit's $305 million bid to reacquire the company's assets was approved by the bankruptcy court in mid-2025. She is also an active angel investor based in Mountain View, California, focusing on Human Capital/HRTech, BioTech, Diagnostics, Digital Health, and Health IT at seed and Series B, with checks between $5K and $50K, including investments in World Labs, Solace, Gameto, Midi Health, and Orchid.
Previous investments
Similar Investors
JJ Richa
Pre Seed
,Seed
,Nikhil Shah
Seed
,Series A
,Pras Hanuma
Pre Seed
,Seed
,Kristen Marumoto
Pre Seed
,Seed
,Edith Yeung
Seed
,Series A
,Danielle Strachman
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.